Abstract:Polyglutamine expansion (≥ 36 residues) within the N-terminal exon-1 of Huntingtin (Httex1) leads to Huntington's disease, a neurodegenerative condition marked by the presence of intranuclear Htt inclusions. Notably, the polyglutamine tract in Httex1 is flanked by an N-terminal coiled-coil domain - N17 (17 amino acids), which undergoes self-association to promote the formation of soluble Httex1 oligomers and brings the aggregation-prone polyQ tracts in close spatial proximity. However, the mechanisms underlying the subsequent conversion of soluble oligomers into insoluble β-rich aggregates with increasing polyQ length, remain unclear. Current knowledge suggests that expansion of the polyQ tract increases its helicity, and this favors its oligomerization and aggregation. In addition, studies utilizing photocrosslinking, conformation-specific antibodies and a stable coiled-coil heterotetrametric system fused to polyQ indicate that domain "cross-talk" (i.e., interdomain interactions) may play a role in the emergence of toxic conformations and the conversion of Httex1 oligomers into fibrillar aggregates. Here, we performed extensive atomistic molecular dynamics (MD) simulations (aggregate time ~ 0.7 ms) to uncover the interplay between structural transformation and domain "cross-talk" on the conformational ensemble and oligomerization landscape of Httex1. Notably, our MD-derived ensembles of N17-polyQ monomers validated against 13C NMR chemical shifts indicated that in addition to elevated α-helicity, polyQ expansion also favors transient, interdomain (N17-polyQ) interactions which result in the emergence of β-sheet conformations. Further, interdomain interactions competed with increased polyQ tract α-helicity to modulate the stability of N17-mediated dimers and thereby promoted a heterogenous dimerization landscape. Finally, we observed that the C-terminal proline-rich domain (PRD) promoted condensation of Httex1 through self-interactions involving its P10/P11 tracts while also interacting with N17 to suppress its α-helicity. In summary, our study demonstrates a significant role for domain "cross-talk" in modulating the monomeric structural ensemble and self-assembly of Httex1.

Charge within Nt17 peptides modulates huntingtin aggregation and initial lipid binding events

Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates

Oligomerization of Huntingtin N-Terminal Fragment on a Phospholipid Bilayer Revealed by Molecular Dynamics Simulations

Oxidation Promotes Distinct Huntingtin Aggregates in the Presence and Absence of Membranes.

Soluble N-terminal Fragment of Mutant Huntingtin Protein Impairs Mitochondrial Axonal Transport in Cultured Hippocampal Neurons.

Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation.

Inhibitor-based modulation of huntingtin aggregation mechanisms reduces fibril toxicity

Unraveling the Molecular Complexity of N-Terminus Huntingtin Oligomers: Insights into Polymorphic Structures

Huntingtin Forms Toxic Nh2-Terminal Fragment Complexes That Are Promoted By The Age-Dependent Decrease In Proteasome Activity

Cholesterol impacts the formation of huntingtin/lipid complexes and subsequent aggregation

The polyglutamine domain is the primary driver of seeding in huntingtin aggregation

Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers.

Transient interdomain interactions modulate the monomeric structural ensemble and self-assembly of Huntingtin Exon 1

Free-Energy Landscape of the Amino-Terminal Fragment of Huntingtin in Aqueous Solution

Natural osmolytes remodel the aggregation pathway of mutant huntingtin exon 1.

N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington’s disease

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

Accumulation of N-terminal Mutant Huntingtin in Mouse and Monkey Models Implicated As a Pathogenic Mechanism in Huntington's Disease

Polyglutamine Length-Dependent Interaction of Hsp40 and Hsp70 Family Chaperones with Truncated N-terminal Huntingtin: Their Role in Suppression of Aggregation and Cellular Toxicity.

Blocking the ability of huntingtin to bind membranes: a therapeutic strategy for Huntingtons disease